The Latest Breaking News from CVS

The Cigna Group has outperformed the Nasdaq Composite over the past year and analysts remain bullish about the stock’s prospects.

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

Jools Lebron has become TikTok’s satirical Emily Post, with etiquette for everything from job interviews to drag shows

The major benchmarks couldn't hold on to early gains as selling pressure returned to risk assets.

CVS Health said pressure in its benefits segment prompted another cut to its full-year forecast. Here's what you need to know.

September S&P 500 E-Mini futures (ESU24) are trending up +0.91% this morning, extending the rebound from Monday’s dramatic selloff, supported by remarks from a senior Bank of Japan official ruling out further rate hikes during periods of market instability, while investors awaited a new batch of earnings reports.

Markets are, at least in the short term, selling every bounce they have and this should be remembered when analyzing news and earnings this week. Here are 5 things to watch this week in the Market.

In a three-day hearing this week in the case against Richard Allen, damning testimony came to light about the alleged murder weapon, jailhouse confessions and the role of an Odinist cult

CVS Health has underperformed the broader market over the past year, but Wall Street analysts still maintain a moderately optimistic view of the stock's prospects.

CVS Health is all set to announce its second-quarter results next month, and analysts are projecting a double-digit decline in the company’s bottom-line figure.

Thanks to clever inventions and investments from venture capitalists, the average American can head to CVS and purchase kits to test for drug use, sexually transmitted diseases, AIDs, diabetes, blood pressure and cholesterol.